SEATTLE, WA--(Marketwired - Oct 4, 2013) - Atossa Genetics Inc. (NASDAQ: ATOS), The Breast Health Company, will host a conference call at 5:45 pm Eastern Time today to discuss the Company's voluntary recall of its ForeCYTE Breast Health Test; Mammary Aspiration Specimen Cytology Test (MASCT) System, which was announced today at 5:00 pm Eastern Time.

To listen to the call by phone, interested parties within the U.S. may dial 866-652-5200. International callers should dial 412-317-6060. All callers should ask for the Atossa Genetics conference call. The conference call will also be available through a live webcast at http://services.choruscall.com/links/atossa131003.html.

A replay of the call will be available one hour after the end of the call through November 4, 2013, and can be accessed via Atossa's website or by dialing 877-344-7529 (domestic) or 412-317-0088 (international). The replay conference ID number is 10034877.

About Atossa Genetics, Inc.

Atossa Genetics, Inc. is focused on the commercialization of patented, diagnostic medical devices and, through its wholly-owned subsidiary, The National Reference Laboratory for Breast Health, Inc. (NRLBH), patented, laboratory developed tests designed to assess breast health.

The NRLBH is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, Washington.

For additional information, on Atossa and the NRLBH, please visit http://www.atossagenetics.com and http://www.nrlbh.com.

View post:
Atossa Genetics Conference Call and Webcast Notice

Comments are closed.